Loading…
Krystal Biotech, Inc. is projected to rise to $391.27 by 2027, a +28% move from its current price of $306.63. KRYS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $300.82 | $306.76 | $312.81 | +0.04% |
| May 30 | $298.52 | $306.88 | $315.48 | +0.08% |
| May 31 | $296.80 | $307.01 | $317.57 | +0.12% |
| Jun 1 | $295.37 | $307.14 | $319.37 | +0.16% |
| Jun 2 | $294.13 | $307.26 | $320.98 | +0.21% |
| Jun 3 | $293.03 | $307.39 | $322.45 | +0.25% |
| Jun 4 | $292.03 | $307.52 | $323.82 | +0.29% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $292.03 | $307.52 | $323.82 | +0.29% |
| Week 2 | $286.67 | $308.40 | $331.78 | +0.58% |
| Week 3 | $282.82 | $309.29 | $338.25 | +0.87% |
| Week 4 | $279.74 | $310.19 | $343.95 | +1.16% |
| Week 5 | $277.14 | $311.08 | $349.18 | +1.45% |
| Week 6 | $274.89 | $311.98 | $354.07 | +1.74% |
| Week 7 | $272.91 | $312.88 | $358.71 | +2.04% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Krystal Biotech, Inc. is a commercial-stage biotechnology company that discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB).
Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.
Krystal Biotech, Inc. (KRYS) is a healthcare stock currently trading at $299.45.
Its market cap stands at $8.83B, and it ranks 981 by market capitalization.
The price outlook is bullish over the long term, with the forecasted average price rising from $299.45 in 2026 to $515.14 in 2030 and up to $2,865.14 in 2050, while ROI progresses from 0 in 2026 to 72 in 2030 and 856.8 in 2050.
A major floor 22.4% below — a decisive break under it would weaken the trend.
The nearest floor, 15.2% below — buyers have tended to step in here.
The nearest ceiling, 3.2% above — a clean break opens room to run.
A major ceiling 14.4% above — clearing it would confirm fresh momentum.
Key KRYS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of KRYS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $303.01 | Buy | $303.24 | Buy |
| MA 10 | $303.53 | Buy | $301.60 | Buy |
| MA 20 | $295.48 | Buy | $295.75 | Buy |
| MA 50 | $275.19 | Buy | $282.19 | Buy |
| MA 100 | $272.20 | Buy | $266.77 | Buy |
| MA 200 | $230.84 | Buy | $240.85 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 60.62 | Neutral |
| Stoch RSI (14) | 34.25 | Neutral |
| CCI (20) | 57.16 | Neutral |
| Williams %R (14) | -39.39 | Info |
| MACD (12,26,9) | -0.79 | Sell |
| ROC (12) | 0.30 | Buy |
| Bollinger %B (20,2) | 0.67 | Neutral |
| Stochastic %K (14) | 60.61 | Neutral |
| TRIX (15) | 0.50 | Buy |
| Awesome (5,34) | 18.34 | Buy |
| Ultimate (7,14,28) | 55.24 | Neutral |
| Momentum (10) | -3.68 | Sell |
| Aroon Osc (25) | 44.00 | Buy |
| Hull MA (9) | 303.63 | Buy |
| ADX (14) | 21.42 | Buy |
| ATR (14) | 5.41 | Info |
The 30-day technical picture is bullish.
RSI14 is 60, indicating renewed upside momentum. The 50-day simple moving average is $272.96 and the 200-day simple moving average is $229.17, with near-term support at $259.95 and resistance at $316.30.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $244.71 | $306.63 | $426.95 | 0% | Neutral | |
| $318.89 | $391.27 | $503.05 | +28% | Bullish | |
| $345.25 | $431.65 | $569.95 | +41% | Bullish | |
| $391.16 | $496.75 | $669.99 | +62% | Bullish | |
| $422.21 | $543.63 | $746.59 | +77% | Bullish | |
| $490.38 | $639.34 | $892.14 | +109% | Bullish | |
| $592.23 | $781.14 | $1,105.79 | +155% | Bullish | |
| $647.30 | $863.08 | $1,237.91 | +181% | Bullish | |
| $732.71 | $987.02 | $1,432.94 | +222% | Bullish | |
| $762.44 | $1,037.15 | $1,522.82 | +238% | Bullish | |
| $1,231.05 | $1,749.52 | $2,694.66 | +471% | Bullish | |
| $2,105.39 | $3,218.92 | $5,322.67 | +950% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $244.71 | $306.63 | $358.45 | +0.00% |
| June 2026 | $263.54 | $307.60 | $366.12 | +0.32% |
| July 2026 | $271.14 | $318.37 | $382.64 | +3.50% |
| August 2026 | $275.62 | $325.14 | $393.73 | +2.13% |
| September 2026 | $274.54 | $325.11 | $396.11 | -0.01% |
| October 2026 | $280.22 | $333.01 | $408.00 | +2.43% |
| November 2026 | $289.11 | $344.64 | $424.31 | +3.49% |
| December 2026 | $288.72 | $345.20 | $426.95 | +0.16% |
Click any year to see its month-by-month KRYS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The KRYS price prediction for 2026 points to an average of $306.63 (low $244.71, high $426.95) — a potential gain of 0% on today's $306.63. Price action looks broadly range-bound.
In 2027, KRYS is projected to trade between $318.89 and $503.05, averaging $391.27 — a potential gain of +28% from today's $306.63. That is up +28% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Krystal Biotech, Inc.'s 2028 outlook centres on $431.65, within a $345.25 to $569.95 range. That is up +10% on the projected 2027 average. That marks a +41% change versus current levels. Momentum favours further upside here.
By 2029, KRYS could reach as high as $669.99, with a base case around $496.75 and support toward $391.16 — roughly +62% from $306.63. Buyers look set to stay in control over this stretch.
Expect KRYS to range from $422.21 to $746.59 through 2030. The $543.63 average target implies a +77% move from current prices. That is up +9% on the projected 2029 average. Momentum favours further upside here.
The KRYS price prediction for 2031 points to an average of $639.34 (low $490.38, high $892.14) — a potential gain of +109% on today's $306.63. Buyers look set to stay in control over this stretch.
In 2032, KRYS is projected to trade between $592.23 and $1,105.79, averaging $781.14 — a potential gain of +155% from today's $306.63. That is up +22% on the projected 2031 average. Momentum favours further upside here.
Krystal Biotech, Inc.'s 2033 outlook centres on $863.08, within a $647.30 to $1,237.91 range. That is up +10% on the projected 2032 average. That marks a +181% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, KRYS could reach as high as $1,432.94, with a base case around $987.02 and support toward $732.71 — roughly +222% from $306.63. Momentum favours further upside here.
Expect KRYS to range from $762.44 to $1,522.82 through 2035. The $1,037.15 average target implies a +238% move from current prices. That is up +5% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The KRYS price prediction for 2040 points to an average of $1,749.52 (low $1,231.05, high $2,694.66) — a potential gain of +471% on today's $306.63. Momentum favours further upside here.
In 2050, KRYS is projected to trade between $2,105.39 and $5,322.67, averaging $3,218.92 — a potential gain of +950% from today's $306.63. That is up +84% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in KRYS today (≈ 3.261259 KRYS) could be worth
$10,497.74
+$9,497.74 (+950%) by 2050 · US Dollar
Based on the average projected KRYS price of $3,218.92 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in KRYSwould be worth at today's price.
$1,000 invested in KRYS on May 27, 2025 (≈ 7.908264 KRYS) would be worth
$2,424.91
+$1,424.91 (+142.5%) today · 2.42× · US Dollar
Based on a KRYS entry price of $126.45 vs. today's $306.63.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $302.05 | $1,015.16 | +1.5% |
| 1 month ago | $272.75 | $1,124.22 | +12.4% |
| 3 months ago | $276.36 | $1,109.53 | +11.0% |
| 6 months ago | $218 | $1,406.56 | +40.7% |
| 1 year ago | $126.45 | $2,424.91 | +142.5% |
| All time (5.0y) ago | $64.75 | $4,735.6 | +373.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our KRYS forecast.
Our base-case forecast reaches $610.00 around 2031.
Implied market cap at $610.00: $17.98B
The year-by-year forecast shows a neutral stance in 2026 with min $244.71, avg $299.45, max $415.80, and ROI 0. The sentiment is NEUTRAL for 2026.
From 2027 onward the outlook turns bullish, with 2027 avg $378.76, 2028 $414.44, 2029 $470.91, and 2030 avg $515.14 with ROI 72. The forecast continues to trend higher, with 2031 min $455.75, avg $598.42, max $842.44, 2032 min $545.42, avg $724.99, max $1,036.03, 2033 min $598.74, avg $805.06, max $1,166.23, 2034 min $671.89, avg $913.27, max $1,339.76, and 2035 min $692.43, avg $951.00, max $1,411.58, all with bullish sentiment.
Longer horizons show substantial upside: 2040 min $1,104.45, avg $1,589.04, max $2,478.75 with ROI 430.6, and 2050 min $1,842.11, avg $2,865.14, max $4,810.56 with ROI 856.8, both bullish.
Tap a question to reveal the answer.
Avg $515.14; min $397.55; max $713.29; ROI 72; sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward, with average price rising to $515.14 by 2030 and to $2,865.14 by 2050, and ROI reaching 72 by 2030 and 856.8 by 2050. The 2026 outlook is neutral.
Yes. The 2032 forecast max is $1,036.03, while 2030 max is $713.29 and 2031 max is $842.44, so the upside crosses $1,000 in the 2032 horizon.
The current price is $299.45.
Low $261.55; High $342.84.
Krystal Biotech, Inc. Community Discussion
0Share your Krystal Biotech, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.